BRPI0911326A2 - método de melhoria da atividade enzimática - Google Patents

método de melhoria da atividade enzimática

Info

Publication number
BRPI0911326A2
BRPI0911326A2 BRPI0911326A BRPI0911326A BRPI0911326A2 BR PI0911326 A2 BRPI0911326 A2 BR PI0911326A2 BR PI0911326 A BRPI0911326 A BR PI0911326A BR PI0911326 A BRPI0911326 A BR PI0911326A BR PI0911326 A2 BRPI0911326 A2 BR PI0911326A2
Authority
BR
Brazil
Prior art keywords
enzymatic activity
improving enzymatic
improving
activity
enzymatic
Prior art date
Application number
BRPI0911326A
Other languages
English (en)
Inventor
Brian M Paegel
Robert G Blazej
Original Assignee
Allopartis Biotechnologies Inc
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allopartis Biotechnologies Inc, Scripps Research Inst filed Critical Allopartis Biotechnologies Inc
Publication of BRPI0911326A2 publication Critical patent/BRPI0911326A2/pt
Publication of BRPI0911326B1 publication Critical patent/BRPI0911326B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1075—Isolating an individual clone by screening libraries by coupling phenotype to genotype, not provided for in other groups of this subclass
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
BRPI0911326 2008-04-04 2009-04-03 método de seleção para atividade enzimática melhorada em um substrato insolúvel BRPI0911326B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4263708P 2008-04-04 2008-04-04
PCT/US2009/039558 WO2009124296A2 (en) 2008-04-04 2009-04-03 Method of enhancing enzyme activity

Publications (2)

Publication Number Publication Date
BRPI0911326A2 true BRPI0911326A2 (pt) 2016-10-11
BRPI0911326B1 BRPI0911326B1 (pt) 2019-11-26

Family

ID=41136125

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911326 BRPI0911326B1 (pt) 2008-04-04 2009-04-03 método de seleção para atividade enzimática melhorada em um substrato insolúvel

Country Status (9)

Country Link
US (2) US8557742B2 (pt)
EP (1) EP2260130B1 (pt)
AU (1) AU2009231585B2 (pt)
BR (1) BRPI0911326B1 (pt)
CA (1) CA2719211C (pt)
DK (1) DK2260130T3 (pt)
ES (1) ES2443047T3 (pt)
MX (1) MX2010010798A (pt)
WO (1) WO2009124296A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2719211C (en) 2008-04-04 2017-01-24 Allopartis Biotechnologies, Inc. Method of enhancing enzyme activity
WO2016164583A2 (en) 2015-04-07 2016-10-13 Novozymes A/S Methods for selecting enzymes having enhanced activity
US20180355404A1 (en) * 2015-04-07 2018-12-13 Novozymes A/S Methods for selecting enzymes having lipase activity
WO2016196691A2 (en) 2015-06-01 2016-12-08 California Institute Of Technology Compositions and methods for screening t cells with antigens for specific populations
US20190161786A1 (en) 2016-04-07 2019-05-30 Novozymes A/S Methods for selecting enzymes having protease activity
US12258613B2 (en) 2017-03-08 2025-03-25 California Institute Of Technology Pairing antigen specificity of a T cell with T cell receptor sequences
GB2569561A (en) * 2017-12-19 2019-06-26 Sphere Fluidics Ltd Methods for performing biological reactions
WO2020223675A1 (en) 2019-05-02 2020-11-05 The Regents Of The University Of California Laser-induced confocal microscope and microfluidic device for dielectrophoretic fluorescence-activated droplet sorting
AU2020361681A1 (en) 2019-10-10 2022-05-05 1859, Inc. Methods and systems for microfluidic screening

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2342094B (en) 1997-07-07 2002-10-23 Medical Res Council In vitro sorting method
WO2003040342A2 (en) * 2001-11-07 2003-05-15 Integrigen, Inc. Method for generation of modular polynucleotides using solid supports
CN101128601B (zh) * 2003-01-29 2011-06-08 454生命科学公司 核酸扩增和测序的方法
US20050106577A1 (en) * 2003-11-17 2005-05-19 Hashem Akhavan-Tafti Cleavable solid phases for isolating nucleic acids
EP1691792A4 (en) * 2003-11-24 2008-05-28 Yeda Res & Dev COMPOSITIONS AND PROCESSES FOR SORTING IN VITRO OF MOLECULE AND CELL LIBRARIES
EA018577B1 (ru) * 2005-03-15 2013-09-30 Верениум Корпорейшн Целлюлазы, нуклеиновые кислоты, кодирующие их, и способы их получения и применения
US7785854B2 (en) * 2006-08-31 2010-08-31 Iogen Energy Corporation Modified cellulases with increased thermostability, thermophilicity, and alkalophilicity
CA2719211C (en) 2008-04-04 2017-01-24 Allopartis Biotechnologies, Inc. Method of enhancing enzyme activity

Also Published As

Publication number Publication date
AU2009231585A1 (en) 2009-10-08
CA2719211A1 (en) 2009-10-08
US20110046012A1 (en) 2011-02-24
WO2009124296A2 (en) 2009-10-08
US8557742B2 (en) 2013-10-15
AU2009231585B2 (en) 2014-08-14
DK2260130T3 (da) 2014-01-27
EP2260130B1 (en) 2013-10-23
US20140045723A1 (en) 2014-02-13
ES2443047T3 (es) 2014-02-17
EP2260130A2 (en) 2010-12-15
BRPI0911326B1 (pt) 2019-11-26
MX2010010798A (es) 2011-01-21
WO2009124296A3 (en) 2009-12-30
CA2719211C (en) 2017-01-24
EP2260130A4 (en) 2012-04-04

Similar Documents

Publication Publication Date Title
BRPI0915867A2 (pt) 4-fenoximetilpiperidinas como moduladores de atividade de gpr119
ES2673405T8 (es) Derivados de Piridina Pirazolo como inhibidores de la NADPH oxidasa
BRPI0911326A2 (pt) método de melhoria da atividade enzimática
BRPI1015238A2 (pt) diamidas de azetidilina como inibidores de monoaciglicerol lipase
BRPI0911118A2 (pt) composto e compisições como moduladores de atividade de gpr119
PL3056224T3 (pl) Sposób sterylizacji
PT2513105E (pt) Derivados de 2-arilimidazole como inibidores da enzima pde10a
BRPI1013317A2 (pt) método de cimentação
EP2270135A4 (en) GENETICALLY MODIFIED CORYNEFORME BACTERIA FOR THE MANUFACTURE OF ISOPROPANOL
BRPI0807146A2 (pt) Inibidores da atividade da akt
BRPI0907376A8 (pt) fotobiorreator
BRPI0916499A2 (pt) método de produção de biomassa
BRPI0908725A2 (pt) Processo enzimático
BRPI0910854A2 (pt) métodos de tratamento
BR112012013954A2 (pt) derivado de ácido hialurônico, método de preparação do derivado de ácido hialurônico e método de modificação do derivado de ácido hialurônico
EP2496176A4 (en) ENTZELLULARISIERUNGSVERFAHREN
DOP2011000397A (es) Nuevos derivados de fenilimidazol como inhibidores de la enzima pde10a
BRPI1008744A2 (pt) hidrotratamento de caboidratos
BRPI1008778A2 (pt) método de amplificação de modelos de dna ricos em gc
EP2361312A4 (en) OPTIMIZED GARDEN MEDIA
UY33155A (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa
PT2370225E (pt) Redução da formação de acrilamida
BRPI0907000A2 (pt) Evolução direcionada de enzimas grg31 e grg36 epsp sintase
BRPI0924579A2 (pt) método de cultura de organismos fotossintéticos
BRPI1014832A2 (pt) método de aterramento de áreas de empréstimo

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: THE SCRIPPS RESEARCH INSTITUTE (US) , NOVOZYMES A/

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/11/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/11/2019, OBSERVADAS AS CONDICOES LEGAIS

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2822 DE 04-02-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.